About Us

Travera was founded in 2017 to commercialize a breakthrough measurement technology and biomarker developed in the Manalis Laboratory in the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology (MIT).

The company’s initial test is based on this technology; a new measurement tool called the Suspended Microchannel Resonator (SMR) that makes exquisitely precise measurements of the effects of cancer drugs on cancer cells.

Leadership Team


Travera’s leadership team is comprised of experienced business executives and researchers who are responsible for defining and implementing the company’s strategy to offer a test which provides physicians and their patients a personalized approach to cancer treatment .

Development Team




At KV, we fundamentally like large problems that are amenable to technology solutions. We seek out unfair advantages: proprietary and protected technological advances, business model innovations, unique partnerships and top-notch teams.

For more information please visit www.khoslaventures.com.

Horizons Ventures

For information about Horizons Ventures please visit www.horizonsventures.com.

Grey Sky Venture Partners

Grey Sky Venture Partners focuses on discovering and funding exceptional management teams developing compelling, well-protected innovations springing from leading-edge research that have the potential to significantly impact the complex and rapidly changing healthcare system.

We make early-stage investments in healthcare and medical technology companies that seek to improve clinical outcomes, enhance quality of life, or reduce system costs. With a heritage rooted in invention, Grey Sky also brings intellectual property expertise and access to a patent portfolio that can be strategically valuable to young companies.

For more information please visit www.gsvp.com.


MSA is an independent and interdisciplinary investment firm that actively partners with outstanding entrepreneurs in China and other global technology markets to build leading businesses that positively impact the way we work and live. We actively manage over $1.5 billion in venture to growth capital across private and public companies.

For more information please visit www.msacap.com.

The Leukemia and Lymphoma Society

The Leukemia & Lymphoma Society is at the forefront of the fight to cure cancer. We are the largest nonprofit dedicated to creating a world without blood cancers. Since 1949, we’ve invested nearly $1.3 billion in groundbreaking research, pioneering many of today’s most innovative approaches.

For more information please visit www.lls.org.